Annex Advisory Services LLC Increases Stake in UnitedHealth Group Incorporated (NYSE:UNH)

Annex Advisory Services LLC grew its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 30.0% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 54,550 shares of the healthcare conglomerate’s stock after buying an additional 12,595 shares during the quarter. UnitedHealth Group accounts for approximately 0.8% of Annex Advisory Services LLC’s portfolio, making the stock its 29th largest holding. Annex Advisory Services LLC’s holdings in UnitedHealth Group were worth $27,595,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently modified their holdings of the stock. Kathleen S. Wright Associates Inc. purchased a new stake in shares of UnitedHealth Group during the third quarter valued at approximately $27,000. Global Wealth Strategies & Associates grew its holdings in UnitedHealth Group by 152.4% in the 3rd quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate’s stock worth $31,000 after acquiring an additional 32 shares during the last quarter. West Financial Advisors LLC purchased a new stake in shares of UnitedHealth Group during the third quarter worth about $32,000. Quarry LP increased its holdings in UnitedHealth Group by 132.1% during the 2nd quarter. Quarry LP now owns 65 shares of the healthcare conglomerate’s stock valued at $33,000 after purchasing an additional 37 shares during the period. Finally, RPg Family Wealth Advisory LLC purchased a new stake in UnitedHealth Group in the 3rd quarter worth approximately $37,000. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Down 0.1 %

Shares of UnitedHealth Group stock opened at $510.03 on Monday. The company has a market cap of $469.37 billion, a price-to-earnings ratio of 33.23, a price-to-earnings-growth ratio of 1.42 and a beta of 0.62. The company has a quick ratio of 0.91, a current ratio of 0.91 and a debt-to-equity ratio of 0.74. The company’s 50 day moving average is $549.37 and its 200 day moving average is $563.18. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $630.73.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, beating analysts’ consensus estimates of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The company had revenue of $100.81 billion during the quarter, compared to analysts’ expectations of $101.60 billion. During the same quarter in the prior year, the business earned $5.83 earnings per share. UnitedHealth Group’s revenue for the quarter was up 6.8% compared to the same quarter last year. Research analysts anticipate that UnitedHealth Group Incorporated will post 27.6 EPS for the current year.

UnitedHealth Group Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th were paid a $2.10 dividend. The ex-dividend date was Monday, December 9th. This represents a $8.40 annualized dividend and a dividend yield of 1.65%. UnitedHealth Group’s dividend payout ratio (DPR) is 54.72%.

Analyst Upgrades and Downgrades

A number of brokerages recently commented on UNH. UBS Group dropped their price target on UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating for the company in a research note on Wednesday, October 16th. Truist Financial reduced their price target on shares of UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating on the stock in a research report on Monday, January 6th. Piper Sandler cut their price objective on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating on the stock in a research report on Thursday, January 2nd. KeyCorp restated an “overweight” rating and issued a $650.00 target price on shares of UnitedHealth Group in a research note on Friday. Finally, Barclays lowered their price objective on UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating for the company in a research report on Friday. Two investment analysts have rated the stock with a hold rating, nineteen have issued a buy rating and two have issued a strong buy rating to the company. According to MarketBeat.com, the company currently has an average rating of “Buy” and a consensus price target of $627.74.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.